(R)-3-(Boc-Amino)piperidine CAS 309956-78-3 iLinagliptin kunye neAlogliptin Benzoate Ucoceko oluPhakathi ≥99.0% Factory
Ubonelelo loMvelisi iLinagliptin kunye neMidiya eNxulumeneyo:
I-Linagliptin CAS 668270-12-0
ILinagliptin yoMzali iNyucleus ePhakathi CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
I-8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4
I-2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino)piperidine CAS 309956-78-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0
Igama leMchiza | (R) -3-(Boc-Amino)piperidine |
Izithethantonye | (R) -3-(tert-Butoxycarbonylamino)piperidine |
Inombolo yeCAS | 309956-78-3 |
Inombolo yeCAT | RF-PI499 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C10H20N2O2 |
Ubunzima beMolekyuli | 200.28 |
Ukunyibilika | Inyibilika kwiMethanol kunye ne-Ethanol |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo oMhlophe |
Indawo yokunyibilika | 120.0 ~ 125.0℃ |
Amanzi (KF) | ≤0.50% |
Intsalela kwi-Ignition | ≤0.50% |
Ucoceko lweChiral | ≥99.0% |
Ucoceko lweMichiza (GC) | ≥99.0% |
Ukungcola ngokupheleleyo | ≤1.0% |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Umbindi weLinagliptin (CAS: 668270-12-0), iAlogliptin Benzoate (CAS: 850649-62-6) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.
(R) -3- (Boc-Amino) i-piperidine (i-CAS: 309956-78-3) isetyenziswe njenge-reactant yokulungiswa kwe-dipeptidyl peptidase IV inhibitors ephuma kwi-Alogliptin Benzoate (CAS: 850649-62-6).(R) -3- (Boc-Amino) i-piperidine nayo ingasetyenziselwa njenge-intermediate ye-Linagliptin (CAS: 668270-12-0).I-Linagliptin yi-inhibitor ye-dipeptidyl peptidase-4 (i-DPP-4) inoveli enamandla kwaye ekhethiweyo enokuthi isetyenziswe kunyango lwe-2 yeswekile, yamkelwa yi-US FDA ngomhla we-2 kuMeyi ka-2011.